The TGF-β/smad repressor TG-interacting factor 1 (TGIF1) plays a role in radiation-induced intestinal injury independently of a smad signaling pathway

PLoS ONE

Volumn 7, Issue 5, 2012, Pages

  Hneino, Mohammad ^a   François, Agnes ^a   Buard, Valerie ^a   Tarlet, Georges ^a   Abderrahmani, Rym ^a   Blirando, Karl ^a   Hoodless, Pamela A ^b   Benderitter, Marc ^a   Milliat, Fabien ^a  

^a INSTITUT DE RADIOPROTECTION ET DE SÛRETÉ NUCLÉAIRE IRSN   (France)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEIN; SMAD PROTEIN; SMAD7 PROTEIN; SNON PROTEIN; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; DNA BINDING PROTEIN; HOMEODOMAIN PROTEIN; ONCOPROTEIN; REPRESSOR PROTEIN; SERPINE1 PROTEIN, HUMAN; SKI PROTEIN, HUMAN; SKI PROTEIN, MOUSE; SKIL PROTEIN, MOUSE; TGFB1 PROTEIN, MOUSE; TGIF PROTEIN, MOUSE; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; GENE TARGETING; INTESTINE INJURY; MOUSE; NONHUMAN; PROTEIN MODIFICATION; RADIATION ENTEROPATHY; RADIATION EXPOSURE; RADIATION INJURY; RADIATION-INDUCED INTESTINAL INJURY; REPRESSOR GENE; SIGNAL TRANSDUCTION; ANIMAL; C57BL MOUSE; GENETICS; INTESTINE; METABOLISM; WESTERN BLOTTING;

MUS;

ANIMALS; BLOTTING, WESTERN; DNA-BINDING PROTEINS; HOMEODOMAIN PROTEINS; INTESTINES; MICE; MICE, INBRED C57BL; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTO-ONCOGENE PROTEINS; REPRESSOR PROTEINS; SMAD PROTEINS; SMAD7 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84860479296     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0035672     Document Type: Article

References (48)

1. Bentzen SM, (2006) Preventing or reducing late side effects of radiation therapy: radiobiology meets molecular pathology. Nat Rev Cancer 6: 702-713.
2. Barnett GC, West CM, Dunning AM, Elliott RM, Coles CE, et al. (2009) Normal tissue reactions to radiotherapy: towards tailoring treatment dose by genotype. Nat Rev Cancer 9: 134-142.
3. Denham JW, Hauer-Jensen M, (2002) The radiotherapeutic injury-a complex 'wound'. Radiother Oncol 63: 129-145.
4. Anscher MS, (2010) Targeting the TGF-beta1 pathway to prevent normal tissue injury after cancer therapy. Oncologist 15: 350-359.
5. Martin M, Lefaix J, Delanian S, (2000) TGF-beta1 and radiation fibrosis: a master switch and a specific therapeutic target? Int J Radiat Oncol Biol Phys 47: 277-290.
6. Anscher MS, Kong FM, Jirtle RL, (1998) The relevance of transforming growth factor beta 1 in pulmonary injury after radiation therapy. Lung Cancer 19: 109-120.
7. Robbins ME, O'Malley Y, Zhao W, Davis CS, Bonsib SM, (2001) The role of the tubulointerstitium in radiation-induced renal fibrosis. Radiat Res 155: 481-489.
8. Wang J, Zheng H, Sung CC, Richter KK, Hauer-Jensen M, (1998) Cellular sources of transforming growth factor-beta isoforms in early and chronic radiation enteropathy. Am J Pathol 153: 1531-1540.
9. Randall K, Coggle JE, (1996) Long-term expression of transforming growth factor TGF beta 1 in mouse skin after localized beta-irradiation. Int J Radiat Biol 70: 351-360.
10. Anscher MS, Crocker IR, Jirtle RL, (1990) Transforming growth factor-beta 1 expression in irradiated liver. Radiat Res 122: 77-85.
11. Kraft M, Oussoren Y, Stewart FA, Dorr W, Schultz-Hector S, (1996) Radiation-induced changes in transforming growth factor beta and collagen expression in the murine bladder wall and its correlation with bladder function. Radiat Res 146: 619-627.
12. Milliat F, Francois A, Isoir M, Deutsch E, Tamarat R, et al. (2006) Influence of endothelial cells on vascular smooth muscle cells phenotype after irradiation: implication in radiation-induced vascular damages. Am J Pathol 169: 1484-1495.
13. Kruse JJ, Floot BG, te Poele JA, Russell NS, Stewart FA, (2009) Radiation-induced activation of TGF-beta signaling pathways in relation to vascular damage in mouse kidneys. Radiat Res 171: 188-197.
14. Milliat F, Sabourin JC, Tarlet G, Holler V, Deutsch E, et al. (2008) Essential role of plasminogen activator inhibitor type-1 in radiation enteropathy. Am J Pathol 172: 691-701.
15. Massague J, Seoane J, Wotton D, (2005) Smad transcription factors. Genes Dev 19: 2783-2810.
16. Scharpfenecker M, Floot B, Russell NS, Ten Dijke P, Stewart FA, (2009) Endoglin haploinsufficiency reduces radiation-induced fibrosis and telangiectasia formation in mouse kidneys. Radiother Oncol 92: 484-491.
17. Schultze-Mosgau S, Blaese MA, Grabenbauer G, Wehrhan F, Kopp J, et al. (2004) Smad-3 and Smad-7 expression following anti-transforming growth factor beta 1 (TGFbeta1)-treatment in irradiated rat tissue. Radiother Oncol 70: 249-259.
18. Haydont V, Riser BL, Aigueperse J, Vozenin-Brotons MC, (2008) Specific signals involved in the long-term maintenance of radiation-induced fibrogenic differentiation: a role for CCN2 and low concentration of TGF-beta1. Am J Physiol Cell Physiol 294: C1332-1341.
19. Flanders KC, Major CD, Arabshahi A, Aburime EE, Okada MH, et al. (2003) Interference with transforming growth factor-beta/Smad3 signaling results in accelerated healing of wounds in previously irradiated skin. Am J Pathol 163: 2247-2257.
20. Flanders KC, Sullivan CD, Fujii M, Sowers A, Anzano MA, et al. (2002) Mice lacking Smad3 are protected against cutaneous injury induced by ionizing radiation. Am J Pathol 160: 1057-1068.
21. Yan X, Chen YG, (2011) Smad7: not only a regulator, but also a cross-talk mediator of TGF-β signalling. Biochem J 434: 1-10.
22. Deheuninck J, Luo K, (2009) Ski and SnoN, potent negative regulators of TGF-beta signaling. Cell Res 19: 47-57.
23. Wotton D, Lo RS, Lee S, Massague J, (1999) A Smad transcriptional corepressor. Cell 97: 29-39.
24. Itoh S, ten Dijke P, (2007) Negative regulation of TGF-beta receptor/Smad signal transduction. Curr Opin Cell Biol 19: 176-184.
25. Bartholin L, Melhuish TA, Powers SE, Goddard-Leon S, Treilleux I, et al. (2008) Maternal Tgif is required for vascularization of the embryonic placenta. Dev Biol 319: 285-297.
26. Aguilella C, Dubourg C, Attia-Sobol J, Vigneron J, Blayau M, et al. (2003) Molecular screening of the TGIF gene in holoprosencephaly: identification of two novel mutations. Hum Genet 112: 131-134.
27. Hamid R, Patterson J, Brandt SJ, (2008) Genomic structure, alternative splicing and expression of TG-interacting factor, in human myeloid leukemia blasts and cell lines. Biochim Biophys Acta 1779: 347-355.
28. Hamid R, Brandt SJ, (2009) Transforming growth-interacting factor (TGIF) regulates proliferation and differentiation of human myeloid leukemia cells. Mol Oncol 3: 451-463.
29. Bartholin L, Powers SE, Melhuish TA, Lasse S, Weinstein M, et al. (2006) TGIF inhibits retinoid signaling. Mol Cell Biol 26: 990-1001.
30. Wotton D, Lo RS, Swaby LA, Massague J, (1999) Multiple modes of repression by the Smad transcriptional corepressor TGIF. J Biol Chem 274: 37105-37110.
31. Fukasawa H, Yamamoto T, Togawa A, Ohashi N, Fujigaki Y, et al. (2004) Down-regulation of Smad7 expression by ubiquitin-dependent degradation contributes to renal fibrosis in obstructive nephropathy in mice. Proc Natl Acad Sci U S A 101: 8687-8692.
32. Fukasawa H, Yamamoto T, Togawa A, Ohashi N, Fujigaki Y, et al. (2006) Ubiquitin-dependent degradation of SnoN and Ski is increased in renal fibrosis induced by obstructive injury. Kidney Int 69: 1733-1740.
33. Huang Y, Border WA, Noble NA, (2006) Perspectives on blockade of TGFbeta overexpression. Kidney Int 69: 1713-1714.
34. Tan R, Zhang J, Tan X, Zhang X, Yang J, et al. (2006) Downregulation of SnoN expression in obstructive nephropathy is mediated by an enhanced ubiquitin-dependent degradation. J Am Soc Nephrol 17: 2781-2791.
35. Mar L, Hoodless PA, (2006) Embryonic fibroblasts from mice lacking Tgif were defective in cell cycling. Mol Cell Biol 26: 4302-4310.
36. Andarawewa KL, Paupert J, Pal A, Barcellos-Hoff MH, (2007) New rationales for using TGFbeta inhibitors in radiotherapy. Int J Radiat Biol 83: 803-811.
37. Barcellos-Hoff MH, Derynck R, Tsang ML, Weatherbee JA, (1994) Transforming growth factor-beta activation in irradiated murine mammary gland. J Clin Invest 93: 892-899.
38. Scharpfenecker M, Kruse JJ, Sprong D, Russell NS, Ten Dijke P, et al. (2009) Ionizing radiation shifts the PAI-1/ID-1 balance and activates notch signaling in endothelial cells. Int J Radiat Oncol Biol Phys 73: 506-513.
39. Ehrhart EJ, Segarini P, Tsang ML, Carroll AG, Barcellos-Hoff MH, (1997) Latent transforming growth factor beta1 activation in situ: quantitative and functional evidence after low-dose gamma-irradiation. Faseb J 11: 991-1002.
40. Jobling MF, Mott JD, Finnegan MT, Jurukovski V, Erickson AC, et al. (2006) Isoform-specific activation of latent transforming growth factor beta (LTGF-beta) by reactive oxygen species. Radiat Res 166: 839-848.
41. Liu ZM, Tseng JT, Hong DY, Huang HS, (2011) Suppression of TG-interacting factor sensitizes arsenic trioxide-induced apoptosis in human hepatocellular carcinoma cells. Biochem J 438: 349-358.
42. Seo SR, Lallemand F, Ferrand N, Pessah M, L'Hoste S, et al. (2004) The novel E3 ubiquitin ligase Tiul1 associates with TGIF to target Smad2 for degradation. Embo J 23: 3780-3792.
43. Melhuish TA, Wotton D, (2000) The interaction of the carboxyl terminus-binding protein with the Smad corepressor TGIF is disrupted by a holoprosencephaly mutation in TGIF. J Biol Chem 275: 39762-39766.
44. Dai C, Liu Y, (2004) Hepatocyte growth factor antagonizes the profibrotic action of TGF-beta1 in mesangial cells by stabilizing Smad transcriptional corepressor TGIF. J Am Soc Nephrol 15: 1402-1412.
45. Demange C, Ferrand N, Prunier C, Bourgeade MF, Atfi A, (2009) A model of partnership co-opted by the homeodomain protein TGIF and the Itch/AIP4 ubiquitin ligase for effective execution of TNF-alpha cytotoxicity. Mol Cell 36: 1073-1085.
46. Lo RS, Wotton D, Massague J, (2001) Epidermal growth factor signaling via Ras controls the Smad transcriptional co-repressor TGIF. Embo J 20: 128-136.
47. Chou CH, Chen SU, Cheng JC, (2009) Radiation-induced interleukin-6 expression through MAPK/p38/NF-kappaB signaling pathway and the resultant antiapoptotic effect on endothelial cells through Mcl-1 expression with sIL6-Ralpha. Int J Radiat Oncol Biol Phys 75: 1553-1561.
48. Dent P, Yacoub A, Fisher PB, Hagan MP, Grant S, (2003) MAPK pathways in radiation responses. Oncogene 22: 5885-5896.